Besides the induction of PD-L1 expression in tumor cells, IL-27 may have additional immune-suppressive activities through the induction of IL-10-producing or PD-L1-expressing regulatory-type CD4+ T cells, such as described in autoimmunity and GVHD models [51,52,53,54,55]. Here, IL10 is linked to graft versus host disease.